Distribution of valproate to subdural cerebrospinal fluid, subcutaneous extracellular fluid, and plasma in humans: A microdialysis study

Epilepsia

Volumn 42, Issue 2, 2001, Pages 256-261

  Lindberger, Martin ^a   Tomson, Torbjörn ^a   Wallstedt, Lars ^a   Ståhle, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antiepileptic drugs; Epilepsy; Microdialysis; Pharmacokinetics; Valproate

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; PHENOBARBITAL; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CORRELATION FUNCTION; DRUG BINDING; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DURA MATER; ELECTROENCEPHALOGRAM; EPILEPSY; EXTRACELLULAR FLUID; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MALE; MICRODIALYSIS; PATIENT MONITORING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TREATMENT PLANNING;

ADMINISTRATION, ORAL; ADULT; ANTICONVULSANTS; BLOOD-BRAIN BARRIER; BRAIN; CEREBROSPINAL FLUID; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; EXTRACELLULAR SPACE; FEMALE; HUMANS; MALE; MICRODIALYSIS; MONITORING, PHYSIOLOGIC; SUBDURAL SPACE; VALPROIC ACID;

EID: 0035097764     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.26600.x     Document Type: Article

References (28)

1. Measurement of neurotransmitter release by intracranial dialysis
2. Introduction to microdialysis
3. Microdialysis sampling for determination of plasma protein binding of drugs
4. A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis
5. Phenytoin concentrations in the human brain: An in vivo microdialysis study
6. Measurement of carbamazepine and carbamazepine epoxide in the human brain using in vivo microdialysis
7. Estimation of topiramate in subdural cerebrospinal fluid, subcutaneous extracellular fluid and plasma: A single case microdialysis study
8. Pharmacokinetics of total and free valproic acid during monotherapy in infants
9. Prediction of unbound serum valproic acid by using in vivo binding parameters
10. Comparison of equilibriurn dialysis, ultrafiltration and ultracentrifugation to determine the plasma protein binding characteristics of a drug: Application to valproic acid
11. Concentration-effect relationships of valproic acid
12. Valproate: An updated review
13. Antiepileptic drugs in saliva and cerebrospinal fluid
14. The distribution of valproic acid between serum and cerebrospinal fluid
15. Plasma protein-binding and CSF concentrations of valproic acid in man following acute oral dosing
16. Human brain, plasma and cerebrospinal fluid concentration of sodium valproate after 72 hours of therapy
17. Comparison of valproate concentrations in human plasma. CSF and brain tissue after administration of different formulations of valproate or valpromide
18. Low and variable presence of valproic acid in human brain
19. Validation of microdialysis sampling for subcutaneous extracellular valproic acid in humans
20. Monitoring free extracellular valproic acid by microdialysis in epileptic patients
21. Use of injectable valproic acid in status epilepticus
22. Distribution of sodium valproate and GABA metabolism in CNS of the rat
23. Pharmacokinetics of sodium valproate in dog and mouse
24. Assesment of valproic acid serum-cerebrospinal transport by microdialysis
25. Physiology of cerebrospinal and interstitial fluids
26. Distribution of valproate across the interface between blood and cerebrospinal fluid
27. Contribution of probenecid-sensitive anion transport processes at the brain capillary endothelium and choroid plexus to the efficient efflux of valproic acid from the central nervous system
28. Subcutaneous microdialysis in rats correlates with carbamazepine concentrations in plasma and brain